Arcturus Therapeutics Holdings Inc. (ARCT)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director | 906.5k | -- | 1972 |
| Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary | 687.5k | -- | 1979 |
| Mr. Andrew H. Sassine MBA | CFO & Director | 687.5k | -- | 1964 |
| Mr. Lance Kurata | Chief Legal Officer | 600k | -- | -- |
| Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing | -- | -- | -- |
| Ms. Natasha O. Bowman | Chief Human Resources Officer | -- | -- | -- |
| Mr. Kevin T. Skol | Chief Business Officer | -- | -- | -- |
| Dr. Juergen Froehlich FCPh, M.D., MBA | Chief Medical Officer | -- | -- | 1956 |
| Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer | -- | -- | -- |
| Ms. Roberta Duncan | Chief Strategy Officer | -- | -- | -- |
Arcturus Therapeutics Holdings Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 174
Description
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
May 12, 2025 at 8:00 PM UTC
Arcturus Therapeutics Holdings Inc. Earnings Date